Name: Zenas BioPharma, Inc. (ZBIO) Cash Flow Statement
Creator: FinSpry

Zenas BioPharma Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Zenas BioPharma, Inc. (ZBIO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-156.99	-37.12	-119.28
Depreciation & Amortization	0.14	0.11	0.08
Stock Based Compensation	10.82	3.50	0.74
Change in Working Capital	25.43	-8.04	7.97
Change in Accounts Payable	11.74	-0.42	1.09
Change in Other Working Capital	13.69	-7.62	31.58
Other Operating Activities	1.53	1.03	31.58
Net Cash from Operating Activities	-119.67	-30.53	-65.65
Investing Activities
Capital Expenditures	-0.13	-0.02	-2.20
Purchases of Investments	-30.42	0.00	0.00
Sales/Maturities of Investments	6.00	0.00	-2.00
Net Cash from Investing Activities	-30.55	-0.02	-2.20
Financing Activities
Common Stock Issued	240.91	0.12	0.00
Other Financing Activities	-6.33	0.00	0.00
Net Cash from Financing Activities	412.96	20.12	59.39
Summary
Effect of Forex Changes on Cash	0.16	0.08	-0.04
Net Change in Cash	262.89	-10.35	-8.46
Cash at Beginning of Period	56.94	67.30	75.80
Cash at End of Period	319.83	56.94	67.30
Free Cash Flow	-119.81	-30.55	-67.85